Turning Lung Cancer Screening into a National Program at European Cancer Summit 2026 – Lung Cancer Europe
Lung Cancer Europe/LinkedIn

Turning Lung Cancer Screening into a National Program at European Cancer Summit 2026 – Lung Cancer Europe

Lung Cancer Europe shared on X:

“Most Lung Cancer in Europe is still found at a late stage.

At the European Cancer Summit 2026, Lung Cancer Europe President Debra Montague joined Tilly Metz, Vice-President of the European Parliament, with speakers from the European Commission, IARC and others. They discussed risk reduction, cancer screening and faster routes to early diagnosis.

The 2022 EU Council Recommendation put lung cancer screening on the agenda. Only a few countries have turned it into a national program. Thank you European Cancer Organisation for bringing these voices together.”

Lung Cancer Europe

About European Cancer Summit 2026

The European Cancer Summit 2026, organized by the European Cancer Organisation (ECO), takes place on November 18-19, 2026, with related EU-funded project events following on November 20. Held in a hybrid format both online and in person at The Hotel Brussels (Bd de Waterloo 38, Brussels, Belgium), the summit brings together clinicians, researchers, policymakers, patient advocates, and industry leaders under the theme ‘Strengthening Cancer Care: Securing a Healthy, Equitable, Resilient and Competitive Europe‘.

The scientific and policy agenda is structured around four main pillars:

  • Prevention and Early Detection: Reimagining Europe’s cancer prevention pathway, moving from risk reduction to earlier diagnosis.
  • Digital Innovation and Clinical Trials: Leveraging AI, digital technologies, and clinical research to improve patient outcomes and maintain Europe’s global competitiveness in oncology.
  • Resilient Health Systems: Addressing workforce challenges, healthcare sustainability, and cross-border collaboration across European member states.
  • Equity and Quality of Life: Reducing disparities in access to care, advancing geriatric oncology, and launching ECO’s new work on Patient-Reported Outcome Measures (PROMs) to better capture person-centered endpoints across the cancer pathway.

The summit is co-chaired by ECO Board Member and Ghent University Professor of Surgical Oncology Wim Ceelen, alongside ECO Patient Advisory Committee Co-Chair and Melanoma Patient Network Europe Vice-President Gilliosa Spurrier-Bernard. ECO President Isabel Rubio also leads key sessions.

You can also read: European Cancer Summit 2026: From Risk Reduction to Early Diagnosis: Reimagining Europe’s Cancer Prevention Pathway

European Cancer Summit 2026